Prenatal Spinal Muscular Atrophy
New York
Approved
Genes
Conditions
- Spinal Muscular Atrophy
Clinical Utility
- Molecular confirmation of a clinical diagnosis
- Identification of at-risk family members
- Assist with treatment/ management decisions
- Recurrence risk assessment
Lab Method
- MLPA
Test Code
TF33
CPT Codes*
81329x1
ABN Required
No
Turnaround Time**
2 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing